Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune (Idiopathic) Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07599280
What this trial is testing

Universal STAR-T Cell Injection in R/R Autoimmune Diseases.

Who this might be right for
Immune Thrombocytopenia
Jian Zhu 6
Not applicableNot Yet RecruitingNCT07680010
What this trial is testing

Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus

Who this might be right for
Immune Thrombocytopenic Purpura ( ITP )Systemic Lupus Erythematosus (SLE)
University Hospital, Bordeaux 105
Large-scale testing (Phase 3)Study completedNCT02201290
What this trial is testing

A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Novartis Pharmaceuticals 9
Post-approval studies (Phase 4)UnknownNCT05861297
What this trial is testing

Immune Thrombocytopenia Management in Adults

Who this might be right for
Immune Thrombocytopenia Purpura
Nahda University 467
Large-scale testing (Phase 3)UnknownNCT02751593
What this trial is testing

Thrombocytopenia in Gestational Period

Who this might be right for
Immune ThrombocytopeniaPregnancy
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT06853444
What this trial is testing

ESG206 in Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Shanghai Escugen Biotechnology Co., Ltd 84
Not applicableStudy completedNCT01974232
What this trial is testing

A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 33
Testing effectiveness (Phase 2)WithdrawnNCT00161564
What this trial is testing

A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT01880047
What this trial is testing

Safety and Efficacy of Eltrombopag at Escalated Doses

Who this might be right for
Immune ThrombocytopeniaPlatelet Disorder
Weill Medical College of Cornell University 35
Not applicableUnknownNCT03183284
What this trial is testing

Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic Purpra

Who this might be right for
Immune Thrombocytopenia
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Testing effectiveness (Phase 2)UnknownNCT02338414
What this trial is testing

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Samsung Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT02401061
What this trial is testing

PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT03102593
What this trial is testing

Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
argenx 38
Not applicableUnknownNCT04311593
What this trial is testing

Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenia
Assiut University 68
Not applicableUnknownNCT04735588
What this trial is testing

Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP

Who this might be right for
Immune ThrombocytopeniaITPCovid19+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 140
Not applicableEnded earlyNCT01386723
What this trial is testing

End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 35
Not applicableUnknownNCT04214951
What this trial is testing

Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 100
Large-scale testing (Phase 3)UnknownNCT03692754
What this trial is testing

Atorvastatin in Management of Newly Diagnosed ITP

Who this might be right for
Immune ThrombocytopeniaPurpura, Thrombocytopenic
Shandong University 30
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Next Page